Connetics sells Ridaura rights

CNCT sold its rights to Ridaura, a rheumatoid arthritis therapeutic, to Prometheus Laboratories (San Diego, Calif.) for $9 million in cash and a royalty on annual sales of more than $4 million. CNCT s...